Serum heat shock protein 27 antigen and antibody levels appear to be related to the macrovascular complications associated with insulin resistance: a pilot study.
Heat shock protein 27 (Hsp27) is over-expressed when cells are exposed to stressful conditions that include oxidative stress. Oxidative stress has been implicated in the pathogenesis of cardiovascular disease (CVD), diabetes and insulin resistance. We have investigated the concentrations of serum Hsp27 antigen and antibodies in subjects from different glycaemic categories, who either did or did not have established CVD. Serum Hsp27 antigen and antibody levels (immunoglobulins M and G (IgM and IgG)) were determined by enzyme-linked immunosorbent assays (ELISAs) in 68 individuals: 26 with normal glucose tolerance (NGT), 10 with (+) and 16 without (-) a history of CVD and 42 individuals with varying degrees of glucose intolerance (GI; 21 with and 21 without a history of CVD). Insulin sensitivity was determined in each subject using indices derived from the homeostasis model assessment of sensitivity and the insulin sensitivity index for glycaemia. Serum Hsp27 concentrations were significantly higher in GI (+CVD) subjects compared to GI (-CVD) subjects (p = 0.03), NGT (-CVD) subjects (p = 0.02) and NGT (+CVD) subjects (p = 0.04) and were positively correlated to fasting plasma glucose for all subjects (r = 0.28, p = 0.03). IgM antibody levels were significantly higher in GI (+CVD) subjects compared to NGT (-CVD) group (p = 0.02) and were inversely related to fasting insulin concentrations (r = -0.27, p = 0.04) and the 2-h insulin concentrations (r = -0.29, p = 0.03) for all subjects. Serum IgG antibody levels were higher in GI (+CVD) group compared to GI (-CVD) group (p = 0.06). In conclusion, Hsp27 and its antibody concentrations appear to relate to the presence of cardiovascular complications in patients with GI.
Burut
Dayangku Fatiha Pengiran
DF
Faculty of Health & Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK.
Borai
Anwar
A
Livingstone
Callum
C
Ferns
Gordon
G
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000097:blood* / Q000276:immunology; D001786:Blood Glucose / Q000032:analysis; D002318:Cardiovascular Diseases / Q000209:etiology / Q000276:immunology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism; D018149:Glucose Intolerance / Q000150:complications / Q000276:immunology; D006442:Glycated Hemoglobin / Q000032:analysis; D055551:HSP27 Heat-Shock Proteins / Q000097:blood* / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008875:Middle Aged; D010865:Pilot Projects
D000906:Antibodies; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D055551:HSP27 Heat-Shock Proteins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007328:Insulin; C517652:hemoglobin A1c protein, human